1. Home
  2. ELVN vs MXL Comparison

ELVN vs MXL Comparison

Compare ELVN & MXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • MXL
  • Stock Information
  • Founded
  • ELVN 2016
  • MXL 2003
  • Country
  • ELVN United States
  • MXL United States
  • Employees
  • ELVN N/A
  • MXL N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • MXL Semiconductors
  • Sector
  • ELVN Health Care
  • MXL Technology
  • Exchange
  • ELVN Nasdaq
  • MXL Nasdaq
  • Market Cap
  • ELVN 927.8M
  • MXL 1.0B
  • IPO Year
  • ELVN 2020
  • MXL 2010
  • Fundamental
  • Price
  • ELVN $17.77
  • MXL $11.39
  • Analyst Decision
  • ELVN Strong Buy
  • MXL Buy
  • Analyst Count
  • ELVN 4
  • MXL 8
  • Target Price
  • ELVN $37.25
  • MXL $20.21
  • AVG Volume (30 Days)
  • ELVN 361.5K
  • MXL 1.0M
  • Earning Date
  • ELVN 05-14-2025
  • MXL 07-23-2025
  • Dividend Yield
  • ELVN N/A
  • MXL N/A
  • EPS Growth
  • ELVN N/A
  • MXL N/A
  • EPS
  • ELVN N/A
  • MXL N/A
  • Revenue
  • ELVN N/A
  • MXL $361,192,000.00
  • Revenue This Year
  • ELVN N/A
  • MXL $24.12
  • Revenue Next Year
  • ELVN N/A
  • MXL $19.30
  • P/E Ratio
  • ELVN N/A
  • MXL N/A
  • Revenue Growth
  • ELVN N/A
  • MXL N/A
  • 52 Week Low
  • ELVN $13.30
  • MXL $8.35
  • 52 Week High
  • ELVN $30.03
  • MXL $26.59
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 49.54
  • MXL 48.36
  • Support Level
  • ELVN $15.81
  • MXL $11.33
  • Resistance Level
  • ELVN $17.54
  • MXL $12.00
  • Average True Range (ATR)
  • ELVN 1.30
  • MXL 0.48
  • MACD
  • ELVN -0.04
  • MXL -0.06
  • Stochastic Oscillator
  • ELVN 38.06
  • MXL 20.19

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About MXL MaxLinear Inc.

MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.

Share on Social Networks: